Skip to main content
OpenTrials

Clinical trial condition

Small Cell Lung Carcinoma

Explore clinical trials studying Small Cell Lung Carcinoma. Study availability and eligibility vary by location and protocol.

820 public trials 196 recruiting studies
Refine in advanced search Browse all conditions

Small Cell Lung Carcinoma trial results

Active, Not Recruiting

Predicting Responsiveness in Oncology Patients Based on Host Response Evaluation During Anti Cancer Treatments

NCT04056247

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +23 more
Locations
  • Birmingham VAHCS Birmingham, Alabama, United States
  • Mayo Clinic Jacksonville, Florida, United States
  • University of Miami Miami, Florida, United States
  • Florida Cancer Specialist and Research Institute Orlando, Florida, United States
View all 41 locations
View Trial Details
Active, Not Recruiting

Thoracic Radiotherapy Plus Maintenance Durvalumab After First Line Carboplatin and Etoposide Plus Durvalumab in Extensive-stage Disease Small Cell Lung Cancer (ED-SCLC).

NCT04472949

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Lung Cancer, +9 more
Locations
  • Kantonsspital Aarau Aarau, Switzerland
  • Universitaetsspital Basel Basel, Switzerland
  • IOSI Ospedale Regionale di Bellinzona e Valli Bellinzona, Switzerland
  • Inselspital Bern Bern, Switzerland
View all 14 locations
View Trial Details
Active, Not Recruiting

NutriCare Plus a Medically Tailored Meal Intervention Among Patients With Lung Cancer

NCT04986670

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +17 more
Locations
  • Tufts Medical Center Boston, Massachusetts, United States
  • The James Cancer Hospital Columbus, Ohio, United States
  • Fox Chase Cancer Center Philadelphia, Pennsylvania, United States
  • MD Anderson Cancer Center Houston, Texas, United States
View Trial Details
Active, Not Recruiting

Chemotherapy and Immunotherapy in Extensive-Stage Small-Cell Lung Cancer With Thoracic Radiotherapy

NCT05796089

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Extensive-stage Small-cell Lung Cancer, +8 more
Locations
  • Westmead Hospital Sydney, New South Wales, Australia
  • Blacktown Hospital Sydney, New South Wales, Australia
  • Liverpool Hospital Sydney, New South Wales, Australia
  • Royal Brisbane and Women's Hospital Brisbane, Queensland, Australia
View Trial Details
Active, Not Recruiting

Pembrolizumab/Vibostolimab (MK-7684A) or Atezolizumab in Combination With Chemotherapy in First Line Treatment of Extensive-Stage Small Cell Lung Cancer (MK-7684A-008/KEYVIBE-008)

NCT05224141

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Lung Diseases, +7 more
Locations
  • Infirmary Cancer Care ( Site 0022) Mobile, Alabama, United States
  • Los Angeles Hematology Oncology Medical Group ( Site 0006) Los Angeles, California, United States
  • VA West Los Angeles Medical Center ( Site 0004) Los Angeles, California, United States
  • Boca Raton Regional Hospital-Lynn Cancer Institute ( Site 0014) Boca Raton, Florida, United States
View all 140 locations
View Trial Details
Active, Not Recruiting

Two Schedules of Hyperfractionated Thoracic Radiotherapy in Limited Disease Small Cell Lung Cancer

NCT02041845

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Lung Diseases, +7 more
Locations
  • Rigshospitalet København Copenhagen, Denmark
  • Odense University Hospital Odense, Denmark
  • Ålesund sykehus Ålesund, Norway
  • Haukeland Universitetssykehus Bergen, Norway
View all 22 locations
View Trial Details

Related conditions